- Tytuł:
- Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial
- Autorzy:
- Źródło:
- In The Lancet 5-11 March 2022 399(10328):945-955
Czasopismo naukowe